Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 6, 1997, Pages 1738-1745

  Gauvreau, G M ^c   Jordana, M ^a   Watson, R M ^c   Cockcroft, D W ^c   O'Byrne, P M ^b  

^a ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; METHACHOLINE; SALBUTAMOL;

ADULT; AIRWAY RESISTANCE; ALLERGENICITY; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS;

EID: 0031452631     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.6.96-08042     Document Type: Article

References (35)

1. Bradley, B. L., M. Azzawi, M. Jacobson, B. Assoufi, J. V. Collins, A. A. Irani, L. B. Schwartz, S. R. Durham, P. K. Jeffery, and A. B. Kay. 1991. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from alopic subjects with asthma: comparison with biopsy specimens from alopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J. Allergy Clin. Immunol. 88:661-674.
2. Kirby, J. G., F. E. Hargreave, G. J. Gleich, and P. M. O'Byrne. 1987. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am. Rev. Respir. Dis. 136:379-383.
3. Pin, I., P. G. Gibson, R. Kolendowicz, A. Girgis-Gabardo, J. A. Denburg, F. E. Hargreave, and J. Dolovich. 1992. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 47: 25-29.
4. Cartier, A., N. C. Thomson, P. A. Frith, R. Roberts, and F. E. Hargreave. 1982. Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J. Allergy Clin. Immunol. 70:170-177.
5. Crimi, E., M. Chiaramondia, M. Milanese, G. A. Rossi, and V. Brusasco. 1991. Increased numbers of mast cells in bronchial mucosa after the late-phase asthmatic response to allergen. Am. Rev. Respir. Dis. 144:1282-1286.
6. Aalbers, R., H. F. Kauffman, B. Vrugt, G. H. Keoter, and J. G. R. De Monchy. 1993. Allergen-induced recruitment of inflammatory cells in lavage 3 and 24 h after challenge in allergic asthmatic lungs. Chest 103: 1178-1184.
7. Fahy, J. V., J. Liu, H. Wong, and H. A. Boushey. 1994. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. 1994. J. Allergy Clin. Immunol. 93:1031-1039.
8. Pin, I., A. P. Freitag, P. M. O'Byrne, A. Girgis-Gabardo, R. M. Watson, J. Dolovich, J. A. Denburg, and F. E. Hargreave. 1992. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am. Rev. Respir. Dis. 145:1265-1269.
9. Pizzichini, E., M. M. M. Pizzichini, A. Efthimiadis, S. Evans, M. M. Morris, D. Squillace, G. J. Gleich, J. Dolivich, and F. E. Hargreave. 1996. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am. J. Respir. Crit. Care Med. 154:308-317.
10. Gauvreau, G. M., J. Doctor, R. M. Watson, M. Jordana, and P. M. O'Byrne. 1996. Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. Am. J. Respir. Crit. Care Med. 154:1267-1271.
11. Barnes, P. J. 1986. Neural control of human airways in health and disease. Am. Rev. Respir. Dis. 134:1289-1314.
12. Church, M. K., and J. Hiroi. 1987. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and albuterol. Br. J. Pharmacol. 90:421-429.
13. Panettieri, R. A., Jr., A. L. Lazaar, E. Pure, and S. Albelda. 1995. Activation of cAMP-dependent pathways in human airway smooth muscle cells inhibits TNF-α-induced ICAM-1 and VCAM-1 expression and T lymphocyte adhesion. J. Immunol. 154:2358-2365.
14. Kerrebijn, K. F., E. E. M. van Essen-Zandvliet, and J. J. Neijens. 1987. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J. Allergy Clin. Immunol. 79:653-659.
15. Vathenen, A. S., A. J. Knox, B. G. Higgins, J. R. Britton, and A. E. Tattersfield. 1988. Rebound increase in bronchial responsiveness after treatment with inhaled terhutaline. Lancet i:554-557.
16. Cockcroft, D. W., C. P. McParland, S. A. Britto, V. A. Swystun, and B. C. Rutherford. 1993. Regular inhaled albuterol and airway responsiveness to allergen. Lancet 342:833-837.
17. Cockcroft, D. W., P. M. O'Byrne, V. A. Swystun, and R. Bhagat. 1995. Regular use of inhaled albuterol and the allergen-induced late asthmatic response. J. Allergy Clin. Immunol. 96:44-49.
18. Manolitsas, D. N., J. Wang, J. L. Devalia, C. J. Trigg, A. E. McAulay, and R. J. Davies. 1995. Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma. Am. J. Respir. Crit. Care Med. 151: 1925-1930.
19. Inman, M. D., R. Watson, D. W. Cockcroft, B. J. O. Wong, F. E. Hargreave, and P. M. O'Byrne. 1995. Reproducibility of allergen-induced early and late asthmatic responses. J. Allergy Clin. Immunol. 95:1191-1195.
20. Dahl, R., P. Venge, and I. Olsson. 1978. Variations of blood eosinophils and eosinophil cationic protein in serum in patients with bronchial asthma. Allergy 33:211-215.
21. Cockcroft, D. M. 1985. Measure of airway responsiveness to inhaled histamine or methacholine: method of continuous aerosol generation and tidal breathing inhalation. In F. E. Hargreave and A. J. Woolcock, editors. Airway Responsiveness: Measurement and Interpretation. Astra Pharmaceuticals Canada Ltd., Mississauga, ON 22-28.
22. O'Byrne, P. M., J. Dolovich, and F. E. Hargreave. 1987. Late asthmatic response. Am. Rev. Respir. Dis. 136:740-756.
23. Cockcroft, D. W., K. Y. Murdock, J. Kirby, and F. E. Hargreave. 1987. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am. Rev. Respir. Dis. 135:264-267.
24. Popov, T. A., R. Gottschalk, R. Kilendowicz, J. Dolovich, P. Powers, and F. E. Hargreave. 1994. The evaluation of a cell dispersion method of sputum examination. Clin. Exp. Allergy 24:778-783.
25. Girgis-Gabardo, A., N. Kanai, J. A. Denburg, F. E. Hargreave, M. Jordana and J. Dolovich. 1994. Immunocytochemical detection of granulocyte-macrophage colony-stimulating factor and eosinophil cationic protein in sputum cells. J. Allergy Clin. Immunol. 93:945-947.
26. Nonaka, M., R. Nonaka, K. Wooley, E. Adelroth, K. Miura, Y. Ockhawara, M. Glibetic, K. Nakano, P. O'Byrne, J. Dolovich, and M. Jordana. 1995. Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. J. Immunol. 155:3234-3244.
27. Johnston, N. W., and J. Bienenstock. 1974. Abolition of non-specific fluorescent staining of eosinophils. J. Immunol. Methods 4:189-194.
28. Filley, W. V., G. M. Kephart, D. E. Holley, and G. J. Gleich. 1982. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet 2(8288): 11-16.
29. Snedecor, G. W., and W. G. Cochran. 1989. Statistical Methods, 8th ed. Iowa State University Press, Ames. 55-57, 374-396.
30. Virchow, J. C., Jr., U. Holscher, and C. Virchow, Sr. 1992. Sputum ECP levels correlate with parameters of airflow obstruction. Am. Rev. Respir. Dis. 146:604-606.
31. Maestrelli, P., P. G. Calcagni, M. Saetta, A. Di Stefano, J. J. Hosselet, A. Santonastaso, L. M. Fabbri and C. E. Mapp. 1994. Sputum eosinophilia after asthmatic responses induced by isocyanates in sensitized subjects. Clin. Exper. Allergy 24:29-34.
32. Gibson, P. G., A. Girgis-Gahardo, M. M. Morris, S. Mattoli, J. M. Kay, J. Dolovich, J. Denburg, and F. E. Hargreave. 1989. Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax 44:693-699.
33. Hayes, M. J., F. Qing, C. G. Rhodes, S. U. Rahman, P. W. Ind, S. Sriskandan, T. Jones, and J. M. B. Hughes. 1996. In vivo quantification of human pulmonary β-adrenoceptors: effect of β-agonist therapy. Am. J. Respir. Crit. Care Med. 154:1277-1283.
34. 2-agonists in asthma. N. Engl. J. Med. 327:1204-1208.
35. 2-adrenoceptor desensitization in cultured human airway smooth muscle. Clin. Science 84:151-157.